癌症
癌症免疫疗法
免疫系统
淋巴结
免疫疗法
淋巴系统
医学
获得性免疫系统
癌细胞
免疫学
炎症
免疫
癌症研究
内科学
作者
Alessandra Vaccaro,Tiarne van de Walle,Mohanraj Ramachandran,Magnus Essand,Anna Dimberg
标识
DOI:10.3389/fimmu.2023.1275378
摘要
Tertiary lymphoid structures (TLS) are lymph node-like aggregates that can form in association with chronic inflammation or cancer. Mature TLS are organized into B and T cell zones, and are not encapsulated but include all cell types necessary for eliciting an adaptive immune response. TLS have been observed in various cancer types and are generally associated with a positive prognosis as well as increased sensitivity to cancer immunotherapy. However, a comprehensive understanding of the roles of TLS in eliciting anti-tumor immunity as well as the mechanisms involved in their formation and function is still lacking. Further studies in orthotopic, immunocompetent cancer models are necessary to evaluate the influence of TLS on cancer therapies, and to develop new treatments that promote their formation in cancer. Here, we review key insights obtained from functional murine studies, discuss appropriate models that can be used to study cancer-associated TLS, and suggest guidelines on how to identify TLS and distinguish them from other antigen-presenting niches.
科研通智能强力驱动
Strongly Powered by AbleSci AI